 ACTON, Mass.--BUSINESS WIRE--Insulet Corporation NASDAQ: PODD Insulet or the Company, the global leader in tubeless insulin pump technology with its Omnipod brand of products, today announced promising results from its latest pivotal trial for the Omnipod 5 Automated Insulin Delivery System Omnipod 5 in very young children. Omnipod 5, the worlds first tubeless, wearable automated insulin delivery AID system that continuously adapts insulin delivery based on glucose levels and trends 